SCHEMBL15570698

SCHEMBL15570698

Cn1ccc2cc(-c3ccc(-c4cncc(N)c4)s3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRF1 P14222 1/20 0.53
PRKCI P41743 1/20 0.48
PIK3CB P42338 2/20 0.44
LRRK2 Q5S007 2/20 0.42
MAOB P27338 1/20 0.42
HSD11B1 P28845 1/20 0.41
SRC P12931 5/20 0.41
ABL1 P00519 3/20 0.41
CCNC P24863 2/20 0.38
CDK8 P49336 2/20 0.38
PIK3CD O00329 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
EPHB4 P54760 1/20 0.38
PRKDC P78527 1/20 0.38
GRM2 Q14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3348340 0.86 PRKCI (0.56) PRKCIPIK3CBLRRK2MAOBHSD11B1
Hydrochloric Acid SCHEMBL14909693 0.85 PRKCI (0.54) PRKCIPIK3CBLRRK2HSD11B1SRC
SCHEMBL16979094 0.83 PRKCI (0.55) PRF1PRKCIPIK3CBLRRK2MAOB
SCHEMBL26071105 0.75 SRC (0.44) PRF1PRKCIPIK3CBLRRK2MAOB
SCHEMBL15572059 0.74 SNCA (0.46) PRF1PRKCIPIK3CBLRRK2MAOB
SCHEMBL15571979 0.73 PRF1 (0.40) PRF1
SCHEMBL25094217 0.72 HSD11B1 (0.50) PRF1PRKCIPIK3CBMAOBHSD11B1
SCHEMBL20924118 0.72 PRF1 (0.67) PRF1MAOB
SCHEMBL25094161 0.71 MAOB (0.43) PRF1PRKCIPIK3CBLRRK2MAOB
SCHEMBL20604841 0.71 HSD11B1 (0.51) PRKCIPIK3CBLRRK2MAOBHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2888251-B1 PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF PETER MACCALLUM CANCER INST (AU) 2019-04-24 EP disclosed
EP-2888251-B1 PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF PETER MACCALLUM CANCER INST (AU) 2019-04-24 EP disclosed
US-9896443-B2 Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof PETER MACCALLUM CANCER INSTITUTE (AU) 2018-02-20 US disclosed
US-9896443-B2 Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof PETER MACCALLUM CANCER INSTITUTE (AU) 2018-02-20 US disclosed
US-20150218150-A1 PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF PETER MACCALLUM CANCER INSTITUTE (AU) 2015-08-06 US disclosed
EP-2888251-A1 PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF Peter MacCallum Cancer Institute (AU) 2015-07-01 EP disclosed
WO-2014028968-A1 PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF PETER MACCALLUM CANCER INSTITUTE (AU) 2014-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218150-A1 PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF PRF1, GZMB, BAK1 PRF1 1/4885PRKCI 1616/4885PIK3CB 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.